Historical Stock Price
DRNA historical stock prices picture
DRNA (DRNA) has the following price history information. Looking back at DRNA historical stock prices for the last five trading days, on December 21, 2021, DRNA opened at $38.00, traded as high as $38.00 and as low as $37.81, and closed at $38.00. Trading volume was a total of 2.59M shares. On December 22, 2021, DRNA opened at $38.10, traded as high as $38.13 and as low as $38.04, and closed at $38.06. Trading volume was a total of 2.17M shares. On December 23, 2021, DRNA opened at $38.04, traded as high as $38.16 and as low as $37.97, and closed at $38.00. Trading volume was a total of 2.39M shares. On December 27, 2021, DRNA opened at $38.21, traded as high as $38.24 and as low as $38.21, and closed at $38.22. Trading volume was a total of 5.56M shares. On December 28, 2021, DRNA opened at $38.22, traded as high as $38.22 and as low as $38.22, and closed at $38.22. Trading volume was a total of 0 shares.

DRNA Historical Stock Prices By Date:

DRNA historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into DRNA shares, starting with a $10,000 purchase of DRNA, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/25/2014
End date: 12/28/2021
Start price/share: $17.19
End price/share: $38.22
Dividends collected/share: $0.00
Total return: 122.34%
Average Annual Total Return: 10.96%
Starting investment: $10,000.00
Ending investment: $22,231.94
Years: 7.68
Date Open High Low Close Volume
12/21/2021 $38.00 $38.00 $37.81 $38.00 2.59M
12/22/2021 $38.10 $38.13 $38.04 $38.06 2.17M
12/23/2021 $38.04 $38.16 $37.97 $38.00 2.39M
12/27/2021 $38.21 $38.24 $38.21 $38.22 5.56M
12/28/2021 $38.22 $38.22 $38.22 $38.22 0
Dicerna Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to utilize ribonucleic acid interference to silence selectively genes that cause or contribute to disease. Nedosiran is Co.'s investigational product candidate for the treatment of primary hyperoxaluria (PH) type 1, PH type 2, and PH type 3. Co.'s GalXC product candidate, RG6346, is for the treatment of chronic hepatitis B virus (HBV) infection. Therapies for HBV include nucleoside analogs and pegylated interferon regimens. Co.'s another GalXC product candidate, belcesiran, is for the treatment of alpha-1 antitrypsin deficiency-associated liver disease.
Date Close
12/21/2021$38.00
12/22/2021$38.06
12/23/2021$38.00
12/27/2021$38.22
12/28/2021$38.22
DRNA is categorized under the Healthcare sector; below are some other companies in the same sector:

DRRX Historical Stock Prices
DRTX Historical Stock Prices
DSCI Historical Stock Prices
DSCO Historical Stock Prices
DVA Historical Stock Prices
DVAX Historical Stock Prices
DVCR Historical Stock Prices
DXCM Historical Stock Prices
DXTR Historical Stock Prices
DYAX Historical Stock Prices

Also explore: DRNA shares outstanding history

Email EnvelopeFree DRNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


DRNA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.